Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2025-06-26 00:00:00 ET · period of report 2025-06-25 · accession 0000950170-25-090196 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-26 | 2025-06-25 | CADL | Martell Christopher | Dir | A - Grant | $4.67 | +111.3K | 111.3K | New | +$520.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-25 | A | A | 111,349 | $4.67 | 111,349 | I By Spouse | — | — | (F2) Shares held by Spouse. |